Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

RYTMRYTM

Showing 0 of 4 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in RHYTHM PHARMACEUTICALS INC

No. Jacobs Levy Equity Management exited its RYTM (Rhythm Pharmaceuticals) position in Q3 2022. Its Q2 2022 13F listed 378,714 shares worth $1.6M. Jacobs Levy Equity Management first reported RYTM in Q3 2019 and held it in 2 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used